145 related articles for article (PubMed ID: 8632417)
1. 3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships.
de Tullio P; Pirotte B; Lebrun P; Fontaine J; Dupont L; Antoine MH; Ouedraogo R; Khelili S; Maggetto C; Masereel B; Diouf O; Podona T; Delarge J
J Med Chem; 1996 Feb; 39(4):937-48. PubMed ID: 8632417
[TBL] [Abstract][Full Text] [Related]
2. 3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: design, synthesis, and pharmacological evaluation.
Pirotte B; Ouedraogo R; de Tullio P; Khelili S; Somers F; Boverie S; Dupont L; Fontaine J; Damas J; Lebrun P
J Med Chem; 2000 Apr; 43(8):1456-66. PubMed ID: 10780901
[TBL] [Abstract][Full Text] [Related]
3. 2-alkyl-3-Alkylamino-2H-Benzo- and pyridothiadiazine 1,1-dioxides: from K+ATP channel openers to Ca++ channel blockers?
Ouedraogo R; Becker B; Boverie S; Somers F; Antoine MH; Pirotte B; Lebrun P; de Tullio P
Biol Chem; 2002 Nov; 383(11):1759-68. PubMed ID: 12530541
[TBL] [Abstract][Full Text] [Related]
4. Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides.
de Tullio P; Becker B; Boverie S; Dabrowski M; Wahl P; Antoine MH; Somers F; Sebille S; Ouedraogo R; Hansen JB; Lebrun P; Pirotte B
J Med Chem; 2003 Jul; 46(15):3342-53. PubMed ID: 12852765
[TBL] [Abstract][Full Text] [Related]
5. 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships.
Pirotte B; Podona T; Diouf O; de Tullio P; Lebrun P; Dupont L; Somers F; Delarge J; Morain P; Lestage P; Lepagnol J; Spedding M
J Med Chem; 1998 Jul; 41(16):2946-59. PubMed ID: 9685234
[TBL] [Abstract][Full Text] [Related]
6. Original 2-alkylamino-6-halogenoquinazolin-4(3H)-ones and K(ATP) channel activity.
Somers F; Ouedraogo R; Antoine MH; de Tullio P; Becker B; Fontaine J; Damas J; Dupont L; Rigo B; Delarge J; Lebrun P; Pirotte B
J Med Chem; 2001 Aug; 44(16):2575-85. PubMed ID: 11472211
[TBL] [Abstract][Full Text] [Related]
7. Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
Boverie S; Antoine MH; Somers F; Becker B; Sebille S; Ouedraogo R; Counerotte S; Pirotte B; Lebrun P; de Tullio P
J Med Chem; 2005 May; 48(10):3492-503. PubMed ID: 15887958
[TBL] [Abstract][Full Text] [Related]
8. Impact of the nature of the substituent at the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides on their opening activity toward ATP-sensitive potassium channels.
Pirotte B; de Tullio P; Boverie S; Michaux C; Lebrun P
J Med Chem; 2011 May; 54(9):3188-99. PubMed ID: 21428460
[TBL] [Abstract][Full Text] [Related]
9. Hydroxylated analogues of ATP-sensitive potassium channel openers belonging to the group of 6- and/or 7-substituted 3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides: toward an improvement in sulfonylurea receptor 1 selectivity and metabolism stability.
de Tullio P; Servais AC; Fillet M; Gillotin F; Somers F; Chiap P; Lebrun P; Pirotte B
J Med Chem; 2011 Dec; 54(24):8353-61. PubMed ID: 22077416
[TBL] [Abstract][Full Text] [Related]
10. Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity.
Pirotte B; de Tullio P; Nguyen QA; Somers F; Fraikin P; Florence X; Wahl P; Hansen JB; Lebrun P
J Med Chem; 2010 Jan; 53(1):147-54. PubMed ID: 19919106
[TBL] [Abstract][Full Text] [Related]
11. 6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cells.
Nielsen FE; Bodvarsdottir TB; Worsaae A; MacKay P; Stidsen CE; Boonen HC; Pridal L; Arkhammar PO; Wahl P; Ynddal L; Junager F; Dragsted N; Tagmose TM; Mogensen JP; Koch A; Treppendahl SP; Hansen JB
J Med Chem; 2002 Sep; 45(19):4171-87. PubMed ID: 12213059
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional quantitative structure-activity relationships of ATP-sensitive potassium (KATP) channel openers belonging to the 3-alkylamino-4H-1,2,4-benzo- and 3-alkylamino-4H-1,2,4-pyridothiadiazine 1,1-dioxide families.
de Tullio P; Dupont L; Francotte P; Counerotte S; Lebrun P; Pirotte B
J Med Chem; 2006 Nov; 49(23):6779-88. PubMed ID: 17154508
[TBL] [Abstract][Full Text] [Related]
13. 3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic B-cells: a new class of potassium channel openers?
Pirotte B; de Tullio P; Lebrun P; Antoine MH; Fontaine J; Masereel B; Schynts M; Dupont L; Herchuelz A; Delarge J
J Med Chem; 1993 Oct; 36(21):3211-3. PubMed ID: 8230110
[No Abstract] [Full Text] [Related]
14. 3-Alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel openers: effect of 6,7-disubstitution on potency and tissue selectivity.
de Tullio P; Boverie S; Becker B; Antoine MH; Nguyen QA; Francotte P; Counerotte S; Sebille S; Pirotte B; Lebrun P
J Med Chem; 2005 Jul; 48(15):4990-5000. PubMed ID: 16033278
[TBL] [Abstract][Full Text] [Related]
15. Preparation and pharmacological evaluation of the R- and S-enantiomers of 3-(2-butylamino)-4H- and 3-(3-methyl-2-butylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide, two tissue selective ATP-sensitive potassium channel openers.
Khelili S; de Tullio P; Lebrun P; Fillet M; Antoine MH; Ouedraogo R; Dupont L; Fontaine J; Felekidis A; Leclerc G; Delarge J; Pirotte B
Bioorg Med Chem; 1999 Aug; 7(8):1513-20. PubMed ID: 10482443
[TBL] [Abstract][Full Text] [Related]
16. New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells.
Nielsen FE; Ebdrup S; Jensen AF; Ynddal L; Bodvarsdottir TB; Stidsen C; Worsaae A; Boonen HC; Arkhammar PO; Fremming T; Wahl P; Kornø HT; Hansen JB
J Med Chem; 2006 Jul; 49(14):4127-39. PubMed ID: 16821773
[TBL] [Abstract][Full Text] [Related]
17. Effect on insulin release of compounds structurally related to the potassium-channel opener 7-chloro-3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide (BPDZ 73): introduction of heteroatoms on the 3-alkylamino side chain of the benzothiadiazine 1,1-dioxide ring.
Boverie S; Antoine MH; de Tullio P; Somers F; Becker B; Sebille S; Lebrun P; Pirotte B
J Pharm Pharmacol; 2001 Jul; 53(7):973-80. PubMed ID: 11480549
[TBL] [Abstract][Full Text] [Related]
18. KATP channel openers: tissue selectivity of original 3-alkylaminopyrido- and 3-alkylaminobenzothiadiazine 1,1-dioxides.
Lebrun P; Becker B; Morel N; Ghisdal P; Antoine MH; de Tullio P; Pirotte B
Biochem Pharmacol; 2008 Jan; 75(2):468-75. PubMed ID: 17920043
[TBL] [Abstract][Full Text] [Related]
19. 1,4,2-Benzo/pyridodithiazine 1,1-dioxides structurally related to the ATP-sensitive potassium channel openers 1,2,4-Benzo/pyridothiadiazine 1,1-dioxides exert a myorelaxant activity linked to a distinct mechanism of action.
Pirotte B; de Tullio P; Florence X; Goffin E; Somers F; Boverie S; Lebrun P
J Med Chem; 2013 Apr; 56(8):3247-56. PubMed ID: 23517501
[TBL] [Abstract][Full Text] [Related]
20. 4,6-Disubstituted 2,2-dimethylchromans structurally related to the K(ATP) channel opener cromakalim: design, synthesis, and effect on insulin release and vascular tone.
Sebille S; de Tullio P; Becker B; Antoine MH; Boverie S; Pirotte B; Lebrun P
J Med Chem; 2005 Jan; 48(2):614-21. PubMed ID: 15658874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
